Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAL-119 in Healthy Volunteers and Participants With Type 1 or Type 2 Diabetes
NCT07901595Phase 2Not yet recruiting
- Sponsor
- Paulex Bio
- Start
- Nov 2026
- Primary completion
- Nov 2027
01
Overview
A Phase 2 trial of PAL-119 in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Paulex Bio. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
PAL-119
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07901595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07901595.